|
Volumn 8, Issue 2, 2001, Pages 109-110
|
Apoptosis in viral pathogenesis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CASPASE INHIBITOR;
CYTOKINE;
GENE PRODUCT;
PROTEIN BCL 2;
PROTEIN P35;
VIRUS ENZYME;
VIRUS PROTEIN;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ADENOVIRUS;
ANIMAL CELL;
ANIMAL TISSUE;
APOPTOSIS;
BACULOVIRUS;
CELL ACTIVATION;
CELL DEATH;
CHICKEN;
CONTROLLED STUDY;
EDITORIAL;
GENETIC ANALYSIS;
GENETIC CODE;
HERPES VIRUS;
HUMAN;
HUMAN CELL;
MYXOMA VIRUS;
NONHUMAN;
PHENOTYPE;
PRIORITY JOURNAL;
REGULATORY MECHANISM;
STRAIN DIFFERENCE;
VIRAL GENETICS;
VIRUS INFECTION;
VIRUS MUTANT;
VIRUS PATHOGENESIS;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
ADENOVIRIDAE;
APOPTOSIS;
BACTERIAL PROTEINS;
CARRIER PROTEINS;
CASPASE 3;
CASPASE 8;
CASPASE 9;
CASPASES;
HIV;
INHIBITOR OF APOPTOSIS PROTEINS;
NEOPLASM PROTEINS;
POXVIRIDAE;
PROTEASE INHIBITORS;
REACTIVE OXYGEN SPECIES;
RECEPTORS, TUMOR NECROSIS FACTOR;
SERPINS;
THYMUS GLAND;
VIRAL PROTEINS;
VIRUSES;
ADENOVIRIDAE;
ANIMALIA;
GALLUS GALLUS;
HERPES;
HERPESVIRIDAE;
MYXOMA VIRUS;
UNIDENTIFIED BACULOVIRUS;
|
EID: 0035090326
PISSN: 13509047
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.cdd.4400820 Document Type: Editorial |
Times cited : (33)
|
References (16)
|